Further, in a neuropathology cohort (n = 316), assessments of NfL, pTau181, and GFAP distinguished AD from FTD with notable accuracy (AUCs of 0.79, 0.96, and 0.81, respectively) [26]. This evidence concerns the gene NEFL and Alzheimer disease.